American Law Institute Sets New Standards for Medical Malpractice, Less Focused on Customary Practices
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Gardasil HPV Vaccine Lawsuit Side effects of the Gardasil HPV vaccine have been linked to reports of serious and debilitating autoimmune injuries. Lawyers review cases nationwide.
Promethazine Recall Issued After Hypertension Pill Found in Bottle June 9, 2014 Russell Maas Add Your Comments About 10,200 bottles of allergy pills are being removed from stores shelves after a report suggests that some bottles may contain blood pressure pills, which could pose a serious risk for consumers and potentially cause adverse health consequences for consumers with allergies.  Zydus Pharmaceuticals issued a promethazine recall on May 28, indicating that a 25 milligram (mg) high blood pressure pill was found in a bottle of the allergy medication. To date, no injuries or severe adverse health reactions have been reported. The recalled promethazine hydrochloride tablets are used to treat seasonal allergies, skin irritations, food or inhalant allergens, and for control of nausea and vomiting after receiving certain types of anesthesia and surgery. Do You Know About… Childhood Diabetes Lawsuits Against Junk Food Industry Lawyers are now pursuing financial compensation for families of children diagnosed with Type II diabetes, fatty liver disease and other chronic illnesses caused by addictive and harmful substances in ultra-processed foods. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… Childhood Diabetes Lawsuits Against Junk Food Industry Lawyers are now pursuing financial compensation for families of children diagnosed with Type II diabetes, fatty liver disease and other chronic illnesses caused by addictive and harmful substances in ultra-processed foods. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In an FDA notification letter, the agency was informed of a report where a consumer found a 25 mg atenolol pill in the allergy pills bottle. Atenolol is used to treat hypertension. The manufacturer’s action has been categorized by the FDA as a Class II recall, indicating the presence of the atenolol in the blood pressure medication may cause temporary or medically reversible adverse health consequences. The recalled allergy pills were manufactured by Zydus Pharmaceuticals USA Inc., of Pennington, New Jersey and were sold nationwide. The recalled pill bottles are labeled with Lot number MN9081 and have an expiration date of September 2015. The pill mix-up came just a little over two months after a similar incident led to a massive Effexor recall. In March, the massive pharmaceutical manufacturer Pfizer had to recall roughly 104,450 bottles of antidepressant Effexor XR and the generic version Venlafaxine after a customer found the heart drug Tikosyn in the antidepressant bottle. The FDA mandated the recall after announcing the accidental ingestion of both the antidepressants and the heart drug could cause fatal reactions. Tags: Atenolol, Effexor, Hypertension, Promethazine, Zydus Pharmaceuticals More Lawsuit Stories Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL March 3, 2025 Study Finds Some Antidepressants Cause Cognitive Decline, Dementia and Fracture Risks March 3, 2025 American Law Institute Sets New Standards for Medical Malpractice, Less Focused on Customary Practices March 3, 2025 2 Comments mekita January 6, 2016 Is there a lawsuit for Atenolol? Gary February 9, 2016 Is there a lawsuit for Atenolol? I know that since I have been taking it I have had all the side effects of this medication but one. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (Posted: today) Judge is calling for Depo-Provera lawyers to submit applications for MDL leadership by the end of the week, indicating that female attorneys should be adequately represented. MORE ABOUT: DEPO-PROVERA LAWSUITJudge Selects Five Depo-Provera Brain Tumor Lawsuits for “Pilot” Trials Weeks After MDL Established (02/25/2025)Depo-Provera Lawyers Will Meet With MDL Judge For Initial Case Management Conference on Friday (02/18/2025)Side Effects of Combined Hormonal Contraceptives Carry Higher Blood Clot Risks Than Others: Study (02/18/2025) Oxbryta Injury Lawsuit Over Discontinued Sickle Cell Disease Drug Set for Trial in June 2027 (Posted: 3 days ago) A federal judge has scheduled an Oxbryta lawsuit to go before a jury on June 7, 2027, which may be the first trial over side effects of the discontinued sickle cell disease drug. MORE ABOUT: OXBRYTA LAWSUITOxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024 (12/30/2024)Lawsuit Alleges Oxbryta Side Effects Resulted in Higher Rate of Vaso-Occlusive Crisis, Other Debilitating Symptoms (11/19/2024)Oxbryta Recall Lawsuits Claim Drug Manufacturer Knew About Fatality Risks for Years (11/08/2024) Schedule To Prepare Bard PowerPort Lawsuits for Bellwether Trials To Be Proposed by Parties (Posted: 4 days ago) A federal judge has ordered lawyers involved in Bard PowerPort lawsuits to submit a joint proposal for preparing the first cases for bellwether trials by March 18. MORE ABOUT: BARD POWERPORT LAWSUITE. Coli Infection Was Caused by AngioDynamics SmartPort Port Catheter, Lawsuit Alleges (03/03/2025)AngioDynamics Seeks to Have Many Chemo Port Lawsuits Dismissed, Arguing Lawsuits Were Filed Too Long After Implant Failed (02/25/2025)AngioDynamics Vortex Port Lawsuit Filed Over Infection, Need for Surgical Removal (02/18/2025)
American Law Institute Sets New Standards for Medical Malpractice, Less Focused on Customary Practices March 3, 2025
Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (Posted: today) Judge is calling for Depo-Provera lawyers to submit applications for MDL leadership by the end of the week, indicating that female attorneys should be adequately represented. MORE ABOUT: DEPO-PROVERA LAWSUITJudge Selects Five Depo-Provera Brain Tumor Lawsuits for “Pilot” Trials Weeks After MDL Established (02/25/2025)Depo-Provera Lawyers Will Meet With MDL Judge For Initial Case Management Conference on Friday (02/18/2025)Side Effects of Combined Hormonal Contraceptives Carry Higher Blood Clot Risks Than Others: Study (02/18/2025)
Oxbryta Injury Lawsuit Over Discontinued Sickle Cell Disease Drug Set for Trial in June 2027 (Posted: 3 days ago) A federal judge has scheduled an Oxbryta lawsuit to go before a jury on June 7, 2027, which may be the first trial over side effects of the discontinued sickle cell disease drug. MORE ABOUT: OXBRYTA LAWSUITOxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024 (12/30/2024)Lawsuit Alleges Oxbryta Side Effects Resulted in Higher Rate of Vaso-Occlusive Crisis, Other Debilitating Symptoms (11/19/2024)Oxbryta Recall Lawsuits Claim Drug Manufacturer Knew About Fatality Risks for Years (11/08/2024)
Schedule To Prepare Bard PowerPort Lawsuits for Bellwether Trials To Be Proposed by Parties (Posted: 4 days ago) A federal judge has ordered lawyers involved in Bard PowerPort lawsuits to submit a joint proposal for preparing the first cases for bellwether trials by March 18. MORE ABOUT: BARD POWERPORT LAWSUITE. Coli Infection Was Caused by AngioDynamics SmartPort Port Catheter, Lawsuit Alleges (03/03/2025)AngioDynamics Seeks to Have Many Chemo Port Lawsuits Dismissed, Arguing Lawsuits Were Filed Too Long After Implant Failed (02/25/2025)AngioDynamics Vortex Port Lawsuit Filed Over Infection, Need for Surgical Removal (02/18/2025)